Viewing StudyNCT05692050



Ignite Creation Date: 2024-05-06 @ 6:32 PM
Last Modification Date: 2024-10-26 @ 2:49 PM
Study NCT ID: NCT05692050
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2023-02-03
First Post: 2023-01-13

Brief Title: Expanded Access to Epcoritamab
Sponsor: AbbVie
Organization: AbbVie

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Keywords:
Name View
Special Access Scheme View
Expanded Access View
Pre-approval Access View
Compassionate Use View
Special Access Program View
Named Patient Basis View